QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CGON

QT49CG Oncology, Inc. Common stock
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
61.08
+0.65+1.08%
OverviewShort InterestFilings
CGONQT49CG Oncology, Inc. Common stock·NASDAQ
OverviewShort InterestFilings
61.08+1.08%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own12.11%
Shs Outstand88.20M
Perf Week5.97%
Market Cap5.33BForward P/E-EPS next Y-2.84Insider Trans0.42%Shs Float-Perf Month-3.51%
Enterprise Value5.30BPEG0.69EPS next Q-0.70Inst Own-Short Float-Perf Quarter-7.26%
Income-195080761.00P/S1051.09EPS this Y-Inst Trans-Short Ratio-Perf Half Y61.37%
Sales5.07MP/B4.68EPS next Y-3.42%ROA-16.45%Short Interest-Perf YTD47.11%
Book/sh12.38P/C-EPS next 5Y-ROE-23.33%52W High75.50 -19.10%Perf Year132.77%
Cash/sh12.20P/FCF-EPS past 3/5Y-ROIC-19.52%52W Low23.65 158.27%Perf 3Y-
Dividend Est.-EV/EBITDA-28.75Sales past 3/5Y-Gross Margin-664.82%Volatility3.48% 3.51%Perf 5Y-
Dividend TTM-EV/Sales1045.94EPS Y/Y TTM-65.25%Oper. Margin-4238.99%ATR (14)2.96Perf 10Y-
Dividend Ex-Date-Quick Ratio31.25Sales Y/Y TTM-Profit Margin-3682.61%RSI (14)51.22Recom2.00
Dividend Gr. 3/5Y-Current Ratio31.30EPS Q/Q-57.78%SMA203.70%Beta1.24Target Price82.57
Payout0.00%Debt/Eq0.01Sales Q/Q-SMA50-5.22%Rel Volume2.29Prev Close60.43
Employees113LT Debt/Eq0.01EarningsAug 07SMA20017.75%Avg Volume984.63KPrice61.08
IPO DateJan 25, 2024Option/ShortYes / YesEPS/Sales Surpr.-22.41% -Net Debt/EBITDA0.14Volume2,258,831Change1.08%
Analyst Ratings
DateActionAnalystRatingTarget
May-14-26ReiteratedTruist Financial$77 → $82
May-11-26ReiteratedRBC CapitalOutperform$79 → $81
May-11-26ReiteratedWedbushOutperform$70 → $80
Apr-27-26ReiteratedRBC CapitalOutperform$73 → $79
Mar-26-26ReiteratedUBS$60 → $90
Feb-10-26ReiteratedTruist Financial$66 → $75
Jan-21-26ReiteratedRBC CapitalOutperform$61 → $73
Jan-16-26ReiteratedPiper SandlerOverweight$55 → $70
Jan-12-26ReiteratedGoldman SachsBuy$55 → $82
Jan-09-26ReiteratedMorgan StanleyOverweight$89 → $93
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
Total Revenue410
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A500
Gross Profit-110
Selling, General and Administrative Excl. Other743410
Research and Development1178246
Other Operating Expense-100
Operating Income-191-115-55
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-30-27-7
Net Income Before Taxes-161-88-49
Income Taxes
000
Consolidated Net Income-161-88-49
Net Income From Continuing Operations-161-88-49
Net Income-161-88-49
EPS (Recurring)-2.08-1.41-1.02
EPS (Basic, Before Extraordinaries)-2.08-1.41-1.02
EPS (Diluted)-2.08-1.41-1.02
EBITDA-160-88-49
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio799.26——
Gross Margin-25.00100.00—
Operating Margin-4,775.00-11,500.00—
Net Margin-4,025.00-8,800.00—
Shares Outstanding776267
Market Capitalization3,197——
Operating Lease Expense
———
Insider Trading Volume
$64.91$57.55$50.19$42.83$35.47● Close Price0.00M12.50M25.00M37.50M50.00MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Mulay JamesDirectorJun 15 '26Option Exercise9.643,92837,8522,620Jun 16 12:00 AM
Mulay JamesDirectorJun 15 '26Sale60.121,31078,7570Jun 16 12:00 AM
POST LEONARD EDirectorJun 04 '26Option Exercise0.602,0001,200116,077Jun 05 12:00 AM
POST LEONARD EDirectorJun 04 '26Sale54.501,00054,5000Jun 05 12:00 AM
Mulay JamesDirectorApr 17 '26Option Exercise36.6331,2001,142,85615,600Apr 20 12:00 AM
Mulay JamesDirectorApr 17 '26Sale73.0115,6001,138,9560Apr 20 12:00 AM
Mulay JamesDirectorMar 16 '26Option Exercise9.643,92837,8523,930Mar 17 12:00 AM
Mulay JamesDirectorMar 16 '26Sale63.501,31083,1850Mar 17 12:00 AM
Kuan ArthurChief Executive OfficerMar 12 '26Option Exercise1.72129,224222,266200,763Mar 13 12:00 AM
Kuan ArthurChief Executive OfficerMar 04 '26Option Exercise1.72205,742353,876139,022Mar 06 12:00 AM
Mulay JamesDirectorJan 09 '26Option Exercise12.0722,290269,03010,491Jan 13 12:00 AM
Mulay JamesDirectorJan 09 '26Sale52.4711,145584,7990Jan 13 12:00 AM
POST LEONARD EDirectorNov 17 '25Option Exercise0.602,0001,200117,077Nov 18 12:00 AM
POST LEONARD EDirectorNov 17 '25Sale41.431,00041,4300Nov 18 12:00 AM
POST LEONARD EDirectorOct 13 '25Option Exercise0.602,0001,200118,077Oct 15 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR